Ian C. Bennett

Ian C. Bennett

Auto-generated profile, based on publicly available information

Ian C. Bennett

Department of Surgery, Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2005 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
IBI. C. Bennett
I. C. Bennett
JGJ. Greenslade
J. Greenslade
HCH. Chiam
H. Chiam

28 January 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
ANAli Naderi
Ali Naderi
JLJi Liu
Ji Liu
IBIan C. Bennett
Ian C. Bennett
We have recently demonstrated that BEX2 is differentially expressed in primary breast tumors and BEX2 expression is required for the Nerve Growth factor inhibition of ceramide‐induced apoptosis in breast cancer. In this study we investigate the functional role of BEX2 in the survival and growth of breast cancer cells. We demonstrate that BEX2 downregulation induces mitochondrial apoptosis and sensitizes breast cancer cells to the pro‐apoptotic effects of ceramide, doxorubicin and staurosporine. In addition, BEX2 overexpression protects the breast cancer cells against mitochondrial apoptosis. We show that this effect of BEX2 is mediated through the modulation of Bcl‐2 protein family, which involves the positive regulation of anti‐apoptotic member Bcl‐2 and the negative regulation of pro‐apoptotic members BAD, BAK1 and PUMA. Moreover, our data suggests that BEX2 expression is required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of cyclin D1 and p21. To further support the significance of BEX2 in the pathogenesis of breast cancer we demonstrate that BEX2 overexpression is associated with a higher activation of the Bcl‐2/NF‐κB pathway in primary breast tumors. Furthermore, we show that BEX2 downregulation results in a higher expression and activity of protein phosphatase 2A. The modulation of protein phosphatase 2A, which is also known to mediate the cellular response to ceramide, provides a possible mechanism to explain the BEX2‐mediated cellular effects. This study demonstrates that BEX2 has a significant role in the regulation of mitochondrial apoptosis and G1 cell cycle in breast cancer.

15 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAnnika Antonsson
Annika Antonsson
SBSeweryn Bialasiewicz
Seweryn Bialasiewicz
RRRebecca J. Rockett
Rebecca J. Rockett
KJKevin Jacob
Kevin Jacob
IBIan C. Bennett
Ian C. Bennett
TSTheo P. Sloots
Theo P. Sloots
Several different viruses have been proposed to play a role in breast carcinogenesis. The aim of this study was to investigate the prevalence of a subset of viruses in breast cancer tissue. We investigated the prevalence of 12 DNA viruses: EBV and CMV from the Herpesviridae family and SV40, BKV, JCV, MCV, WUV, KIV, LPV, HPyV6, HPyV7, and TSV from the Polyomaviridae family in 54 fresh frozen breast tumour specimens. Relevant clinical data and basic lifestyle data were available for all patients. The tissue samples were DNA extracted and real-time PCR assays were used for viral detection. The highest prevalence, 10% (5/54), was found for EBV. MCV, HPyV6, and HPyV7 were detected in single patient samples (2% each), while WUV, KIV, JCV, BKV, LPV, SV40, TSV and CMV were not detected in the 54 breast cancer specimens analysed here. Further investigations are needed to elucidate the potential role of viruses, and particularly EBV, in breast carcinogenesis.

7 January 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
IBIan C. Bennett
Ian C. Bennett
ASApoorva Saboo
Apoorva Saboo

19 October 2011 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
AAAnnika Antonsson
Annika Antonsson
TSTerrence P. Spurr
Terrence P. Spurr
ACAlice C. Chen
Alice C. Chen
GFGlenn D. Francis
Glenn D. Francis
NMNigel McMillan
Nigel McMillan
IBIan C. Bennett
Ian C. Bennett

1 April 2018 in Cancer Letters
Verified
Journal Article
Closed access
OGO.M. Gannon
O.M. Gannon
AAA. Antonsson
A. Antonsson
IBI.C. Bennett
I.C. Bennett
NSN.A. Saunders
N.A. Saunders